pharma

Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil system in Toronto

A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial…

2 weeks ago

Axtria Recognized as Frost & Sullivan’s 2025 Global Company of the Year in Pharma Commercial Solutions

Honored for AI-Driven Innovation, Measurable Client Impact, and Industry-Leading Commercialization ExcellenceBERKELEY HEIGHTS, N.J., March 25, 2026 /PRNewswire/ -- Axtria Inc., a…

3 weeks ago

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1 million)Sales of Olverembatinib increased 81% year-over-year…

3 weeks ago

NIPER Raebareli partners with Roche Pharma to Strengthen Pharmaceutical Education and Research Capability Building Collaboration

NEW DELHI, March 19, 2026 /PRNewswire/ -- Roche Pharma India signed a Memorandum of Understanding (MoU) with National Institute of Pharmaceutical…

4 weeks ago

Zealand Pharma to participate in upcoming investor conferences in March 2026

March 09, 2026 12:01 ET  | Source: Zealand Pharma Press release – No. 5 / 2026 Zealand Pharma to participate…

1 month ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

1 month ago

Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025

MUMBAI, India, March 6, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG:…

1 month ago

The largest pharma show in Asia makes its return to Shanghai this June 2026

SHANGHAI, March 2, 2026 /PRNewswire/ -- CPHI & PMEC China 2026 is set to take place from 16 to 18…

1 month ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage…

2 months ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 17, 2026 18:22 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BridgeBio…

2 months ago